Want to see TSE:AIDR full AI Analyst Report?
AIDR Stock Chart & Stats
C$0.59
--
Market closed
C$0.59
--
Day’s Range― - ―
52-Week RangeC$0.36 - C$0.98
Previous CloseN/A
VolumeN/A
Average Volume (3M)175.17K
Market Cap
C$58.14M
Enterprise ValueC$64.45M
Total Cash (Recent Filing)C$3.50M
Total Debt (Recent Filing)C$527.62K
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding96,894,780
10 Day Avg. Volume215,584
30 Day Avg. Volume175,170
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)15.03
Price to Sales (P/S)30.35
P/FCF Ratio-8.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.55Price Target Upside162.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.07
Revenue Forecast (FY)C$4.79M
Bulls Say, Bears Say
Bulls Say
High Gross MarginSustained ~89% gross margin indicates strong unit economics for the platform and AI-enabled services. High contribution margins provide structural leverage as revenue scales, increasing the potential to cover fixed R&D and SG&A and improve profitability over a multi-quarter horizon.
Rapid Revenue GrowthMaterial top-line growth demonstrates product-market fit and demand for virtual care and AI solutions. Durable revenue expansion supports scaling operating leverage and builds a foundation for future margin improvement if the company can align costs with the growing revenue base.
Conservative LeverageVery low debt relative to equity reduces solvency risk and preserves financial flexibility. A repaired balance sheet (equity improved from prior negative years) gives management runway to invest in product and sales initiatives without immediate refinancing pressure.
Bears Say
Large Operating LossesSignificant recurring operating losses far exceed current revenue, reflecting a cost base not yet matched to scale. This structural deficit must be closed via sustained revenue scale, material cost reductions, or external capital, or else earnings power will remain impaired over coming quarters.
Negative Cash Flow / Cash BurnPersistent negative operating and free cash flow indicates dependence on external financing to fund operations. This constrains strategic options, increases dilution risk if equity raises are needed, and creates runway uncertainty if capital markets tighten over the medium term.
Negative Return On EquityA negative ROE shows the company is eroding shareholder capital rather than generating returns. Even with improved equity, sustained negative ROE signals management has not yet converted resources into profitable growth, a structural weakness for long-term value creation.
Rocket Doctor AI News
AIDR FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was C$0.36 and its highest was C$0.98 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is C$58.14M.
When is Rocket Doctor AI’s upcoming earnings report date?
Rocket Doctor AI’s upcoming earnings report date is Aug 27, 2026 which is in 53 days.
How were Rocket Doctor AI’s earnings last quarter?
Currently, no data Available
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Undervalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 96,894,780 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in TSE:AIDR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.
AIDR Stock 12 Month Forecast
Average Price Target
C$1.55
▲(162.71% Upside)
Technical Analysis
Diagnos
―
Vitalhub
―
nDatalyze Corp
―
UniDoc Health Corp
―
DiagnaMed Holdings Corp.
―
Options Prices
Currently, No data available
---








